InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Mendelsohn Alan, Directeur Médical. Director active across 1 company, notably Timber Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €8k. Activity tracked since 3 March 2021. The latest transaction was disclosed on 20 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Alan Mendelsohn is the Chief Medical Officer at Timber Pharmaceuticals, Inc. He is responsible for overseeing the company's medical activities and clinical research. His medical expertise is essential in guiding product development initiatives and ensuring compliance with regulations.